JAAOS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Am Acad Orthop Surg, Vol 8, No 5, September/October 2000, 277-284.
© 2000 the American Academy of Orthopaedic Surgeons

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Watterson, J. R.
Right arrow Articles by Esdaile, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Watterson, J. R.
Right arrow Articles by Esdaile, J. M.

Viscosupplementation: Therapeutic Mechanisms and Clinical Potential in Osteoarthritis of the Knee

John R. Watterson, MD, FRCPC and John M. Esdaile, MD, MPH, FRCPC

Dr. Watterson is Rheumatology Fellow, University of British Columbia, Vancouver. Dr. Esdaile is Professor of Medicine, University of British Columbia, and Scientific Director, Arthritis Research Centre of Canada, Vancouver.

Reprint requests: Dr. Esdaile, Scientific Director, Arthritis Research Centre of Canada, 895 West 10th Avenue, Vancouver, British Columbia, Canada V5Z 1L7.

Viscosupplementation by means of intra-articular injections of hyaluronic acid has been used to treat osteoarthritis of the knee. The proposed mechanisms of action result from the physical properties of hyaluronic acid, as well as from its anti-inflammatory, anabolic, local analgesic, and chrondroprotective effects. Adverse reactions from hyaluronic acid injections into the knee occurred in 8.3% of the 336 patients treated in one study, but at a rate of less than 3% per injection. Reactions were almost always local and generally resolved over 1 to 2 days. Hyaluronic acid injections were approved by the US Food and Drug Administration as a medical device; thus, the level of efficacy demonstrated is less than might have been required for approval as a drug. Several studies have failed to show statistically significant benefit compared with placebo. Furthermore, the treatment is relatively expensive; the cost of the drug for a series of injections is more than $500 per knee. Therefore, widespread use of these agents should be limited until more convincing data on their efficacy are available from well-designed clinical trials.




This article has been cited by other articles:


Home page
Am J Sports MedHome page
E. J. Strauss, J. A. Hart, M. D. Miller, R. D. Altman, and J. E. Rosen
Hyaluronic Acid Viscosupplementation and Osteoarthritis: Current Uses and Future Directions
Am. J. Sports Med., August 1, 2009; 37(8): 1636 - 1644.
[Abstract] [Full Text] [PDF]


Home page
Am J Sports MedHome page
E. Silverstein, R. Leger, and K. P. Shea
The Use of Intra-articular Hylan G-F 20 in the Treatment of Symptomatic Osteoarthritis of the Shoulder: A Preliminary Study
Am. J. Sports Med., June 1, 2007; 35(6): 979 - 985.
[Abstract] [Full Text] [PDF]


Home page
ptjournalHome page
G. D Deyle, S. C Allison, R. L Matekel, M. G Ryder, J. M Stang, D. D Gohdes, J. P Hutton, N. E Henderson, and M. B Garber
Physical Therapy Treatment Effectiveness for Osteoarthritis of the Knee: A Randomized Comparison of Supervised Clinical Exercise and Manual Therapy Procedures Versus a Home Exercise Program
Physical Therapy, December 1, 2005; 85(12): 1301 - 1317.
[Abstract] [Full Text] [PDF]


Home page
J Ultrasound MedHome page
M. A. Pourbagher, M. Ozalay, and A. Pourbagher
Accuracy and Outcome of Sonographically Guided Intra-articular Sodium Hyaluronate Injections in Patients With Osteoarthritis of the Hip
J. Ultrasound Med., October 1, 2005; 24(10): 1391 - 1395.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
S. Morshed, G. R. Huffman, and M. D. Ries
Septic Arthritis of the Hip and Intrapelvic Abscess Following Intra-Articular Injection of Hylan G-F 20. A Case Report
J. Bone Joint Surg. Am., April 1, 2004; 86(4): 823 - 826.
[Full Text] [PDF]


Home page
JBJSHome page
C.-T. Wang, J. Lin, C.-J. Chang, Y.-T. Lin, and S.-M. Hou
Therapeutic Effects of Hyaluronic Acid on Osteoarthritis of the Knee. A Meta-Analysis of Randomized Controlled Trials
J. Bone Joint Surg. Am., March 1, 2004; 86(3): 538 - 545.
[Abstract] [Full Text] [PDF]


Home page
J Am Acad Orthop SurgHome page
M. Ulrich-Vinther, M. D. Maloney, E. M. Schwarz, R. Rosier, and R. J. O'Keefe
Articular Cartilage Biology
J. Am. Acad. Ortho. Surg., November 1, 2003; 11(6): 421 - 430.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
R. Iorio and W. L. Healy
Unicompartmental Arthritis of the Knee
J. Bone Joint Surg. Am., July 3, 2003; 85(7): 1351 - 1364.
[Full Text] [PDF]


Home page
JBJSHome page
A. L. Chen, P. Desai, E. M. Adler, and P. E. Di Cesare
Granulomatous Inflammation After Hylan G-F 20 Viscosupplementation of the Knee : A Report of Six Cases
J. Bone Joint Surg. Am., July 9, 2002; 84(7): 1142 - 1147.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Academy of Orthopaedic Surgeons.